News Website

Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn

Racial disparities in high-risk endometrial subtype diagnoses reported Contemporary Obgyn

Published: Oct. 24, 2024, 6:26 p.m.

Read Full Article

Execution of Kenyan in Saudi Arabia postponed by one year - The Standard

Execution of Kenyan in Saudi Arabia postponed by one year The Standard

Published: Oct. 24, 2024, 2:22 p.m.

Read Full Article

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace

Published: Oct. 24, 2024, 11:46 a.m.

Read Full Article

Shock Diagnosis: Woman Discovers She’s Got Multiple Private Parts - MSN

Shock Diagnosis: Woman Discovers She’s Got Multiple Private Parts MSN

Published: Oct. 24, 2024, 11:16 a.m.

Read Full Article

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace

Published: Oct. 24, 2024, 5:36 a.m.

Read Full Article

MPs push Treasury to allocate funds for referral hospitals for waived bills - The Standard

MPs push Treasury to allocate funds for referral hospitals for waived bills The Standard

Published: Oct. 24, 2024, 4:48 a.m.

Read Full Article

Casio to Release MR-G Inspired by the Brilliant Gleam of Japanese Katana Swords - bastillepost.com

Casio to Release MR-G Inspired by the Brilliant Gleam of Japanese Katana Swords bastillepost.com

Published: Oct. 24, 2024, 1 a.m.

Read Full Article

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation PR Newswire

Published: Oct. 24, 2024, 12:08 a.m.

Read Full Article

Professor Eva Dimitriadis leads breakthrough discovery into cause of unexplained infertility - Neos Kosmos

Professor Eva Dimitriadis leads breakthrough discovery into cause of unexplained infertility Neos Kosmos

Published: Oct. 23, 2024, 11 p.m.

Read Full Article

Prolonged Treatment for Endometriosis May Harm Live Birth Rate in IVF - Medpage Today

Prolonged Treatment for Endometriosis May Harm Live Birth Rate in IVF Medpage Today

Published: Oct. 23, 2024, 10:19 p.m.

Read Full Article

Latest Articles

Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn

Execution of Kenyan in Saudi Arabia postponed by one year - The Standard

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace

Shock Diagnosis: Woman Discovers She’s Got Multiple Private Parts - MSN

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

MPs push Treasury to allocate funds for referral hospitals for waived bills - The Standard

Casio to Release MR-G Inspired by the Brilliant Gleam of Japanese Katana Swords - bastillepost.com

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Professor Eva Dimitriadis leads breakthrough discovery into cause of unexplained infertility - Neos Kosmos

Prolonged Treatment for Endometriosis May Harm Live Birth Rate in IVF - Medpage Today

Subscribe to Our Newsletter